Meridian Bioscience Inc (NASDAQ:VIVO)

Delayed Data
As of Jun 15
 +0.35 / +2.17%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 15.50, with a high estimate of 17.00 and a low estimate of 11.00. The median estimate represents a -5.78% decrease from the last price of 16.45.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -15.08%
Growthannually 5.47%


Growthquarterly -7.75%
Growthannually 5.69%
Key to the earnings and sales forecast charts.